0001415889-21-004934.txt : 20211021 0001415889-21-004934.hdr.sgml : 20211021 20211021163323 ACCESSION NUMBER: 0001415889-21-004934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211019 FILED AS OF DATE: 20211021 DATE AS OF CHANGE: 20211021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harmon Cyrus CENTRAL INDEX KEY: 0001831410 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 211337361 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 form4-10212021_011011.xml X0306 4 2021-10-19 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001831410 Harmon Cyrus C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 true true false false CHIEF TECHNOLOGY OFFICER Common Stock 2021-10-19 4 S 0 7445 27.85 D 1056101 D Common Stock 2021-10-19 4 S 0 4555 28.20 D 1051546 D Common Stock 122028 I See Footnote The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The weighted average sale price for the transaction reported was $27.85, and the range of prices were between $27.60 and $28.00. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $28.20, and the range of prices were between $28.00 and $28.63. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager. /s/ John B. Moriarty, Jr., Attorney-in-Fact 2021-10-20